Quantcast

Latest Becker's muscular dystrophy Stories

2009-06-15 07:00:00

- Funding supports continued focus on rare disorders - SOUTH PLAINFIELD, N.J., June 15 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the receipt of two government grants to support clinical development programs in rare disorders. The U.S. Department of Defense Neurofibromatosis Research Program has awarded an $822,345 grant to support a new open-label Phase 2 clinical trial of PTC's product candidate PTC299 in neurofibromatosis type 2 (NF2), a rare genetic tumor. Separately,...

2009-05-27 16:09:19

U.S. medical scientists say they've developed a new therapy for Duchenne musclar dystrophy, a fatal disease and the most common form of MD in children. Researchers at the University of Minnesota Medical School, using a mouse model, said they were able to substitute for the missing protein dystrophin, which forms a key part of the framework that holds muscle tissue together. The scientists injected dystrophic mice with a protein called utrophin -- a close relative of dystrophin -- that was...

2009-05-27 08:29:28

Researchers at the University of Minnesota Medical School have discovered a new therapy that shows potential to treat people with Duchenne muscular dystrophy, a fatal disease and the most common form of muscular dystrophy in children.In the mouse model, researchers were able to substitute for the missing protein "“ dystrophin, which forms a key part of the framework that holds muscle tissue together "“ that results in the disease, effectively repairing weakened muscle...

da5a87ef0e8b2ad6574eb1d1fc6112831
2009-05-11 16:08:09

Simple, inexpensive blood test could speed diagnostic journey Boys show signs of Duchenne Muscular Dystrophy (DMD) for 2 ½ years before they obtain a diagnosis and disease-specific treatment, about the same length of delay children have endured for the past 20 years despite advances in genetic testing and treatment. A simple and inexpensive blood test for any boy with symptoms and signs of motor delays and abnormalities could speed up the process while pilot studies on...

2009-05-05 13:31:00

Researchers at University of Florida -- Gainesville, University of California -- Los Angeles to Receive $250,000 For Duchenne Muscular Dystrophy Research MIDDLETOWN, Ohio, May 5 /PRNewswire-USNewswire/ -- Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today two recipients of the newly launched End Duchenne Grant...

2009-04-30 15:00:00

Former New York Giants Jim Burt and Bart Oates Help Raise Money and Awareness for Duchenne Muscular Dystrophy FORT LEE, N.J., April 30 /PRNewswire-USNewswire/ -- Pat Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD) announced today that former New York Giant stars Jim Burt and Bart Oates will join hundreds of guests for the 1st Annual Pour for a Cure, supporting PPMD, at the Hyatt Regency in New Brunswick, New Jersey on May 8, 2009. More than just a wine tasting...

2009-04-20 09:37:29

U.S. scientists say they've conducted the first gene therapy trial for a form of muscular dystrophy that disables by weakening hip and shoulder muscles. Researchers from the University of Florida, Nationwide Children's Hospital in Columbus, Ohio, and Ohio State University said they safely transferred a gene to produce a protein necessary for healthy muscle fiber growth into three teenagers with limb-girdle muscular dystrophy. We think this is an important milestone in establishing the...

2009-03-16 13:50:47

Finding lays the foundation for human testing Using a novel genetic technology that covers up genetic errors, researchers funded in part by the National Institutes of Health have developed a successful treatment for dogs with the canine version of Duchenne muscular dystrophy, a paralyzing, and ultimately fatal, muscle disease. The technology, known as "exon skipping" uses tailor-made snippets of DNA-like molecules as molecular "patches." These patches cover up mutant DNA sequences that code...

2009-02-27 13:31:32

Muscular dystrophy, which affects approximately 250,000 people in the United States, occurs when damaged muscle tissue is replaced with fibrous, bony or fatty tissue and loses function. While scientists have identified one protein, dystrophin, as an important piece to curing the disease, another part of the mystery has eluded scientists for the past 14 years. Now, one University of Missouri scientist and his team have identified the location of the genetic material responsible for a molecular...

2009-02-27 00:40:20

A University of Missouri team of scientists identified the location of the genetic material vital to curing muscular dystrophy. Dongsheng Duan said Duchenne muscular dystrophy, which predominantly affects males, is the most common type of muscular dystrophy. Patients with Duchenne muscular dystrophy have a gene mutation that disrupts the production of dystrophin. Absence of dystrophin starts a chain reaction that eventually leads to muscle cell degeneration and death. A previous study by Duan...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related